The Null Hypothesis Redeemed: How Failed Experiments Are Quietly Rebuilding Scientific Knowledge
Photo: SDASM Archives, No restrictions, via Wikimedia Commons
In the spring of 2015, a team of cancer biologists at a mid-sized research university in Ohio spent fourteen months attempting to replicate a widely cited mechanism linking a specific protein pathway to tumor proliferation in pancreatic cells. Their experiments, conducted with meticulous care and substantially larger sample sizes than the original study, produced nothing — no statistically significant relationship, no confirmatory signal, no publishable headline. The team's graduate students moved on to other projects. The data sat unarchived. The scientific community remained unaware that a cornerstone assumption in a busy subfield had quietly failed to hold up under scrutiny.
This scenario is not exceptional. It is, by most accounts, the norm.
The so-called "file drawer problem" — the systematic disappearance of null results from the published scientific record — has been a recognized pathology of academic research for more than four decades. What has changed in recent years is the urgency with which the problem is being addressed, and the institutional mechanisms slowly being constructed to solve it.
A Publishing Ecosystem Built for Confirmation
The structural incentives that discourage the publication of negative findings are deeply embedded in how scientific careers are built and how journals compete for prestige. Impact factors, citation counts, and grant renewal rates all reward novelty and significance. A paper demonstrating that an intervention does not work, or that a previously reported effect cannot be reproduced, faces steep editorial headwinds regardless of its methodological rigor.
A landmark 2012 meta-analysis published in PNAS found that the proportion of positive results in published scientific literature had risen from approximately 70 percent in 1990 to over 85 percent by the mid-2000s across multiple disciplines. The authors, led by Daniele Fanelli, concluded that the trend was inconsistent with genuine improvements in experimental design and more consistent with selective reporting. Put plainly: science was not getting better at asking questions. It was getting better at hiding the answers it did not like.
The consequences extend well beyond academic inefficiency. In pharmaceutical research, the failure to publish negative clinical trial data has contributed to distorted assessments of drug efficacy, a problem documented extensively in the work of physician and science writer Ben Goldacre. In psychology, the replication crisis that erupted publicly in 2011 — when a large-scale replication project found that fewer than half of 100 published studies could be reproduced — was substantially fueled by journals' historical indifference to null findings. In nutrition science, conflicting public health guidance has partly reflected a literature skewed toward positive associations between dietary variables and health outcomes.
Institutions Begin to Move
The response from within the scientific establishment has been gradual but measurable. Several developments over the past decade signal a genuine, if incomplete, paradigm adjustment.
The most structurally significant has been the emergence of registered reports as a publishing format. Under this model, journals evaluate and conditionally accept research proposals before data collection begins, committing to publication regardless of outcome. As of 2024, more than 300 journals across disciplines ranging from neuroscience to economics have adopted registered reports in some form. The format directly decouples editorial acceptance from results, removing the primary incentive to suppress null findings.
Funding agencies have also begun recalibrating their expectations. The National Institutes of Health, responding to congressional pressure and internal audits of research reproducibility, updated its grant reporting requirements to explicitly encourage documentation of negative findings. The NIH's emphasis on rigor and reproducibility, formalized in policy updates beginning in 2016, represents an institutional acknowledgment that the absence of an effect is scientifically meaningful data.
Dedicated outlets for null results have proliferated as well. PLOS ONE, which evaluates submissions on methodological soundness rather than perceived impact, has become one of the largest scientific journals in the world by volume. More specialized venues, including the Journal of Negative Results in Biomedicine and several discipline-specific repositories, have created at least partial infrastructure for findings that the mainstream literature would have once discarded.
When Nothing Happens, Something Is Learned
Perhaps the most compelling argument for valorizing negative results is not philosophical but empirical: null findings have, on multiple occasions, redirected entire research programs toward more productive terrain.
The history of physics offers the most celebrated example. The Michelson-Morley experiment of 1887, designed to detect the luminiferous ether through which light was assumed to travel, found no evidence of the ether's existence. That null result, initially treated as an embarrassing failure, became foundational to the development of special relativity. The experiment's negative outcome was not an absence of knowledge — it was a precise and transformative constraint on what physical theory was required to accommodate.
More recently, large-scale genome-wide association studies have generated substantial null landscapes that proved scientifically generative. When researchers examining genetic contributions to certain psychiatric conditions found that candidate genes identified in earlier, smaller studies failed to replicate across populations of hundreds of thousands of individuals, the null findings forced a reconceptualization of the genetic architecture of those conditions — away from single-gene models and toward polygenic frameworks that have since proven far more empirically robust.
Barriers That Persist
Despite these advances, significant structural resistance remains. Early-career researchers, who bear the greatest professional risk, continue to face disincentives that established scientists can more easily absorb. Tenure and promotion committees at most US research universities still weight publication records in high-impact journals far more heavily than contributions to preprint servers or registered report repositories. The asymmetry places the burden of cultural change disproportionately on those with the least institutional power to effect it.
Peer review itself presents complications. Reviewers trained to evaluate the significance of positive findings may lack frameworks for assessing the quality of null results, making rigorous negative studies vulnerable to rejection on grounds that confuse methodological adequacy with the presence of a detectable effect.
Data sharing mandates, while expanding, remain inconsistently enforced. Without reliable access to raw datasets from studies that were never written up for publication, systematic reviews and meta-analyses continue to operate on a skewed sample of the available evidence.
Toward a More Complete Record
The movement to rehabilitate negative results is, at its core, a movement about epistemic integrity — about whether the published scientific record accurately represents what researchers have actually found, or only what they found convenient to report. The distinction matters enormously for the downstream consumers of that record: clinicians making treatment decisions, policymakers allocating resources, and scientists designing the next generation of studies.
The infrastructure for change exists. Registered reports, open data requirements, preprint culture, and dedicated null-result venues collectively constitute a more hospitable environment for negative findings than has existed at any prior moment in the history of scientific publishing. Whether that infrastructure is used — and used equitably across career stages and institutional contexts — depends on choices that funding agencies, journal editors, university administrators, and researchers themselves will continue to make in the years ahead.
The file drawer is not an inevitable feature of scientific practice. It is a policy choice, and it can be unmade.